Carrington Reports Second Quarter 20...(arydysentery (shigellosis); and El Sohly...)

Date:8/19/2007

ary dysentery (shigellosis); and El Sohly Laboratories for the delivery of a therapeutic preventing the metastasis of certain cancer cells. In the second quarter alone, new licensing agreements include a two-year extension of the development program with Brookwood Pharmaceuticals and a commercial evaluation license with NIH for developing a typhoid vaccine with GelSite(R) polymer.

Conference Call Scheduled

Investors are invited to listen to the conference call scheduled on Thursday, August 16, 2007, at 4.15 p.m. Eastern, 3.15 p.m. Central, by dialing 866-202-0886 in the US or 617-213-8841 internationally. The pass code is 80948721. The call is also being web cast by CCBN and can be accessed at Carrington's website at http://www.carringtonlabs.com. A replay of the call will be available a few hours after the call concludes by dialing 888-286-8010 in the US and 617-801-6888 internationally. The pass code for the replay is 72302282.

The web cast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at http://www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors can access the call via Thomson's password-protected event management site, StreetEvents (http://www.streetevents.com).

About Carrington

Carrington Laboratories, Inc. is an ISO 9001-certified, research-based, biopharmaceutical and consumer products company currently utilizing naturally-occurring complex carbohydrates to manufacture and market products for mucositis, radiation dermatitis, wound and oral care, as well as to manufacture and market the nutraceutical raw material Manapol(R) and cosmetic raw material Hydrapol(TM). Carrington also manufactu
'/>"/>

SOURCE Carrington Laboratories, Inc. Copyright©2007 PR Newswire.

0 GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening